Uloric is a newer generation gout medication that recently received a boxed warning from the FDA due to an increased risk of heart-related death. It is also linked to other adverse cardiovascular events such as heart attack, stroke, unstable angina. At the same time, a safer, more reliable medicine had long been available for a fraction of the price.
In 2019, the FDA determined it will require a boxed warning to be placed on all prescriptions of Uloric. The boxed warning, also known as the “black box warning” is the most severe warning the FDA can assign. It is only used when there is reasonable evidence that a medication is likely to cause serious or life-threatening side effects, in this case, serious cardiovascular events such as heart attack or myocardial infarction, stroke, unstable angina or cardiovascular death.
There has been an increase in heart-related events such as cardiovascular death, heart attack and stroke for those taking Uloric.
Uloric should not be stopped abruptly. Talk to your health care professional if you are considering stopping the medication.
Seek emergency medical attention immediately if any of the following side effects occur while taking Uloric:
A former safety consultant for Uloric manufacturer, Takeda Pharmaceuticals, issued a whistleblower lawsuit where he claimed the company knew about the risks associated with Uloric, yet failed to inform the public. The risks the company allegedly knew about include liver issues, kidney damage, and bone marrow failure.
Also included in the complaint was the allegation that Takeda knew that Uloric could be fatal when combined with select prescription drugs. It went even further to accuse the company of taking steps to conceal the dangers from the public. The lawsuit was eventually dismissed, but it raises bigger ethical questions surrounding Uloric and its manufacturer, Takeda.
Did you or a loved one suffer Heart Attack, Stroke, Unstable Angina or Death while taking Gout Medication Uloric?
Find out if you qualify for compensation.
Find Out MoreConsumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.
This website is not affiliated with any pharmaceutical or medical device company or any trademarked product. Results are not guaranteed. This website provides a free matching service and is not responsible for information or services from third party providers. Consumer Safety Watch is not a law firm. Every case is different and services available can vary.